| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |